Arrowhead Pharmaceuticals Inc. appointed William Waddill as an independent director, effective Jan. 1, 2018.
Most recently, Waddill was senior vice president and CFO of Calithera Biosciences Inc.
Arrowhead Pharmaceuticals appoints director
Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection
S&P Capital IQ Pro | Powered by Advanced Visualization
S&P Capital IQ Pro | Unrivaled Sector Coverage
S&P Capital IQ Pro | Powering Your Edge
Arrowhead Pharmaceuticals appoints director
- Author Tayyeba Irum
- Theme Healthcare & Pharmaceuticals
- Author
- Tayyeba Irum
- Theme
- Healthcare & Pharmaceuticals